Navicare Pharma Private Limited, a active private limited company, was established on 03 May 2011 in Mumbai, Maharashtra, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U24110MH2011PTC216977. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kunal Navin Saxena (Director), Navin Satyapal Sexena (Director). Past directors included Archana Navin Saxena. Its latest AGM occurred on 15 September 2024, with the balance sheet filed on 31 March 2024. It is based at Rusan House, 58-D, Govt. Industrial Estate Charkop, Kandivali (West), Mumbai, Maharashtra, 400067.
U24110MH2011PTC216977
216977
03 May 2011
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Navicare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Navin Saxena | Director | 19 Apr 2013 | Current |
| Navin Satyapal Sexena | Director | 03 May 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Apr 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Navicare Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 101.79% increase. The company also saw a substantial fall in profitability, with a 46.88% decrease in profit. The company's net worth moved up by a moderate rise of 4.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Navicare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Navicare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Navicare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navicare Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Navicare Pharma Private Limited last Annual general meeting of members was held on 15 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Navicare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Kunal Navin Saxena was appointed as a Director was appointed as a Director on 19 Apr 2013 & has been associated with this company since 12 years 7 months . was recorded as a recent event.
Navin Satyapal Sexena was appointed as a Director was appointed as a Director on 03 May 2011 & has been associated with this company since 14 years 7 months . was recorded as a recent event.
Progress on Navicare Pharma Private Limited was registered on 03 May 2011 with Roc Mumbai & aged 14 years 7 months as per MCA records. was documented.
The CIN of Navicare Pharma Private Limited is U24110MH2011PTC216977.
Navicare Pharma Private Limited is headquartered at Rusan House, 58-D, Govt. Industrial Estate Charkop, Kandivali (West), Mumbai, Maharashtra, 400067.
Navicare Pharma Private Limited was incorporated on 03 May 2011.
The current directors of Navicare Pharma Private Limited are
The primary industry of Navicare Pharma Private Limited is Hospital And Medical Care.
Navicare Pharma Private Limited is unlisted.
The authorized capital of Navicare Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Navicare Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX